Smoking cessation in HIV patients: Rate of success and associated factors

HIV Medicine

Volumn 10, Issue 10, 2009, Pages 614-619

  Fuster, M ^a   Estrada, V ^a   Fernandez Pinilla, M C ^a   Fuentes Ferrer, M E ^a   Tellez, M J ^a   Vergas, J ^a   Serrano Villar, S ^a   Fernandez Cruz, A ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Cardiovascular risk; HIV; Smoking cessation

Indexed keywords

AMFEBUTAMONE; ANTIRETROVIRUS AGENT; VARENICLINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTIVATION; PREVALENCE; RISK FACTORS; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 70449356797     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00735.x     Document Type: Article

References (24)

1. Triant VA, Lee H, Hadigan C. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrin Metab 2007, 92:2506-2512.
2. Obel N, Thomsen HF, Kronborg G. Ischemic heart disease in HIV-infected and HIV-uninfected individuals. Clin Infect Dis 2007, 44:1625-1631.
3. Friis-Moller N, Sabin CA, Weber R. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003, 349:1993-2003.
4. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke. Circulation 1997, 96:3243-3247.
5. Banegas JR, Rodriguez-Artalejo F, Dominguez-Rojas V. How much benefit could be obtained from cardiovascular disease intervention programs?. Rev Epidemiol Sante Publique 1992, 40:313-322.
6. Martínez E, Arribas J, López Aldeguer J. Factors associated with a high cardiovascular risk in HIV-infected patients in Spain: a multicenter, nationwide, cross sectional study. . Boston, MA, February 2005 [Abstract 870].
7. Pedrol-Clotet E, Deig-Comerma E, Ribell-Bachs M, Vidal-Castell I, Garcia-Rodriguez S, Soler A. Uso de bupropión en la deshabituación tabáquica en pacientes infectados por el VIH en tratamiento antirretroviral [Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy]. Enferm Infecc Microbiol Clin 2006, 24:509-511.
8. Elzi L, Spoerl D, Voggensperger J. A smoking cessation programme in HIV-infected individuals. Antivir Ther 2006, 11:787-795.
9. Velicer WF, Prochaska JO, Bellis JM. An expert system intervention for smoking cessation. Addict Behav 1993, 18:269-290.
10. Jiménez-Ruiz JI, Riesco Miranda JA, Ramos Pinedo A. Recomendaciones para el tratamiento farmacológico del tabaquismo [Recommendations for pharmacologic treatment in smoking cessation]. Arch Bronconeumol 2008, 44:213-219.
11. Heatherton TF, Kozlowski LT, Frecker RC. The Fagerström test for nicotine dependence. Br J Addict 1991, 86:1119-1127.
12. Marrugat J, Subirana I, Comín E. Validity of an adaptation of the Framingham cardiovascular risk function. J Epidemiol Commun Health 2007, 61:40-47.
13. Feldman JG, Minkoff H, Schneider MF. Association of cigarette smoking with HIV prognosis among women in the ART era. Am J Public Health 2006, 96:1060-1065.
14. Burkhalter JE, Springer CM, Chhabra R. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res 2005, 7:511-522.
15. Hershberger SL, Fisher DG, Reynolds GL. Nicotine dependence and HIV risk behaviors among illicit drug users. Addict Behav 2004, 29:623-625.
16. Fingeret MC, Vidrine DJ, Arduino RC. The association between body image and smoking cessation among individuals living with HIV/AIDS. Body Image 2007, 4:201-206.
17. Webb MS, Vanable PA, Carey MP. Cigarette smoking among HIV-positive men and women. J Behav Med 2007, 30:371-383.
18. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS 2002, 16:39-42.
19. Hogg R, Lima V, Sterne JA. Life expectancy of individuals on combination antiretroviral therapy in high-income countries. Lancet 2008, 372:266-267.
20. Mocroft A, Vella S, Benfield TL. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998, 352:1725-1730.
21. Etter JF, Perneger TV, Ronchi A. Distributions of smokers by stage. Prev Med 1997, 26:580-585.
22. Hyland A, Li Q, Bauer JE. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res 2004, 6((Suppl 3)):363-369.
23. Ramón JM, Bou R, Alkiza ME. The process of change and sex as predictors of the quitting of tobacco consumption. Arch Bronconeumol 1999, 35:488-493.
24. Lemmens V, Oenema A, Knut IK, Brug J. Effectiveness of smoking cessation interventions among adults. Eur J Cancer Prev 2008, 17:535-544.